1. Altuame, Fadie D, Shamseldin, Hanan E, Albatti, Turki H, Abdulwahab, Firdous, Alkuraya, Fowzan S. 2021. PLXNA2 as a candidate gene in patients with intellectual disability. In American journal of medical genetics. Part A, 185, 3859-3865. doi:10.1002/ajmg.a.62440. https://pubmed.ncbi.nlm.nih.gov/34327814/
2. Kajii, Takashi S, Oka, Akira, Hatta, Mitsutoki, Yamashita, Junro, Iida, Junichiro. 2018. PLXNA2 identified as a candidate gene by genome-wide association analysis for mandibular prognathism in human chondrocytes. In Biomedical reports, 9, 253-258. doi:10.3892/br.2018.1128. https://pubmed.ncbi.nlm.nih.gov/30271602/
3. Pijuan, Jordi, Ortigoza-Escobar, Juan Darío, Ortiz, Juan, Palau, Francesc, Hoenicka, Janet. 2021. PLXNA2 and LRRC40 as candidate genes in autism spectrum disorder. In Autism research : official journal of the International Society for Autism Research, 14, 1088-1100. doi:10.1002/aur.2502. https://pubmed.ncbi.nlm.nih.gov/33749153/
4. Mah, S, Nelson, M R, Delisi, L E, Kammerer, S, Braun, A. . Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. In Molecular psychiatry, 11, 471-8. doi:. https://pubmed.ncbi.nlm.nih.gov/16402134/
5. Li, Sisi, Hua, Xuyun, Zheng, Mouxiong, Shan, Chunlei, Xu, Jianguang. 2021. PLXNA2 knockdown promotes M2 microglia polarization through mTOR/STAT3 signaling to improve functional recovery in rats after cerebral ischemia/reperfusion injury. In Experimental neurology, 346, 113854. doi:10.1016/j.expneurol.2021.113854. https://pubmed.ncbi.nlm.nih.gov/34474008/
6. Fujii, Takashi, Iijima, Yoshimi, Kondo, Hitomi, Saitoh, Osamu, Kunugi, Hiroshi. 2007. Failure to confirm an association between the PLXNA2 gene and schizophrenia in a Japanese population. In Progress in neuro-psychopharmacology & biological psychiatry, 31, 873-7. doi:. https://pubmed.ncbi.nlm.nih.gov/17346868/
智鼠故事 
